Asset Details
Do you wish to reserve the book?
Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer
Do you wish to request the book?
Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer
2025
Overview
Oral microbiota have been implicated in pancreatic ductal adenocarcinoma (PDAC) and may contribute to chemotherapy resistance. While previous studies attributed bacteria-induced resistance to indirect host modulation, recent findings suggest a direct mechanism. Escherichia coli expressing long-form cytidine deaminase (CDDL) can degrade gemcitabine, a chemotherapeutic agent, into a non-toxic form, leading to resistance. In contrast, bacteria carrying short form (CDDS) or lacking CDD did not induce resistance. This study investigates whether oral bacteria can cause gemcitabine resistance in PDAC cells through CDD-mediated degradation. Oral microbes associated with PDAC were selected based on CDD isoforms: Aggregatibacter actinomycetemcomitans carrying CDDL, Enterococcus faecalis, Streptococcus mutans, Porphyromonas gingivalis, all carrying CDDS, and Fusobacterium nucleatum lacking CDD. The selected microbes, along with wild-type and CDD-deficient E. coli, were co-incubated with gemcitabine to assess its degradation and PDAC cell proliferation. A. actinomycetemcomitans fully degraded gemcitabine and induced resistance. Surprisingly, CDDS-expressing oral bacteria partially degraded gemcitabine in a strain-dependent manner. Expressing either CDDL or CDDS in CDD-deficient E. coli resulted in equivalent gemcitabine degradation and resistance, indicating that CDD function is independent of isoform length. These findings highlight the role of oral bacteria in gemcitabine resistance and the need for strategies to mitigate microbial-driven resistance in PDAC treatment.
Publisher
MDPI AG,MDPI
Subject
/ Aggregatibacter actinomycetemcomitans
/ Antimetabolites, Antineoplastic - pharmacology
/ Bacteria
/ Carcinoma, Pancreatic Ductal - drug therapy
/ Carcinoma, Pancreatic Ductal - microbiology
/ Cell Proliferation - drug effects
/ Cytidine Deaminase - genetics
/ Cytidine Deaminase - metabolism
/ Deoxycytidine - analogs & derivatives
/ Deoxycytidine - pharmacology
/ E coli
/ Genes
/ HPLC
/ Humans
/ Isoforms
/ Microbiota (Symbiotic organisms)
/ Pancreatic Neoplasms - drug therapy
/ Pancreatic Neoplasms - microbiology
/ Pancreatic Neoplasms - pathology
/ Plasmids
/ Proteins
We currently cannot retrieve any items related to this title. Kindly check back at a later time.